Reginald Giles Stambaugh successfully settles case for brewery fortune heir

Reginald Giles Stambaugh

Palm Beach attorney Reginald Giles Stambaugh successfully settles a case for heir to the Stroh Brewery fortune.

WEST PALM BEACH, FLORIDA, USA , January 30, 2020 /EINPresswire.com/ — Following a successful 12 months for the popular Palm Beach attorney, Reginald Giles Stambaugh wrapped up last year with a string of high profile legal victories, including successfully settling a case on behalf of client Whitney Stroh, an heir to the Stroh Brewery fortune. Certified by The Florida Bar for more than two decades, Stambaugh reflects on the matter, and shares details of several other prominent cases successfully handled during 2019.

"On November 14, 2019, I successfully settled a case for client Whitney Stroh, an heir to the Stroh Brewery fortune," reveals Stambaugh, speaking from his office in Palm Beach, Florida.

In addition to its own brand, Stroh Brewery produced or bought the rights to several other brands, including Augsburger, Schaefer, Erlanger, Lone Star, Old Milwaukee, and Red River, before the company was sold in 2000. "The brand is currently owned and marketed by Pabst Brewing Company in the U.S.," explains Stambaugh, "and, in Canada, by Sleeman Breweries."

Reginald Giles Stambaugh's client, Mr. Stroh, is an heir to the sizable Stroh Brewery fortune. Stambaugh himself, meanwhile, specializes in all facets of real estate law, including transactions, litigation, and estate matters, and heads up the private law practice Stambaugh Law Firm of Palm Beach County, Florida.

Elsewhere in 2019, Stambaugh successfully advocated before Palm Beach Town Council against President Donald J. Trump's Mar a Lago Club when the resort requested approval of a dock that would've violated the declaration of use agreement entered into between the town's council and the current U.S. President.

Reginald Giles Stambaugh also joined the Los Angeles litigation team for the estate of Peter Ausnit, Sr., an heir to the Ziploc storage bag and container brand fortune, to advocate against the mishandling of personal assets of his estate.

Furthermore, the attorney was again recertified as a specialist in real estate law by The Florida Bar in 2019. "I look forward," adds Stambaugh, wrapping up, "to continuing to serve clients, both new and existing alike, throughout 2020 and beyond."

Certified since 1999, Reginald Giles Stambaugh is a Florida Bar licensed real estate attorney. Attorney Stambaugh is top-rated by Martindale-Hubbell, and is scored 10.0 by the Avvo attorney directory. Reginald Giles Stambaugh studied at the Stetson University College of Law in Tampa, Florida. Ranked 1st in trial advocacy by U.S. News & World Report in its best law schools ratings, following his graduation in 1992, Stambaugh returned to his hometown of Palm Beach, Florida, where he remains happily settled almost 30 years later.

Caroline Hunter
Web Presence, LLC
+1 7862338220
email us here


Source: EIN Presswire

Opioid, Heroin, and other drug abuse epidemics being fought at ground level with The Truth About Drugs

The Truth About Drugs Education Package contents are an effective weapon against ignorance of drug dangers

Volunteer with Drug-Free World booklets

A volunteer reaching out to the community with The Truth About Drugs booklets.

Educating people in a park using The Truth About Drugs Booklets

Drug-Free World provides these materials for free in 22 languages

Drug-Free World offers free materials to help schools, parents, and communities educate themselves and others on drugs and their dangers

I am doing independent research on prescription drug abuse by children, and your materials are helpful in my study which will benefit the community.”

— Chemistry Major, Northwestern Oklahoma State University

WASHINGTON, DC, USA, January 30, 2020 /EINPresswire.com/ — The Truth About Drugs is a series of fourteen illustrated drug information booklets containing facts about the most commonly abused drugs.

These booklets were specifically written for young people, but contain facts adults need to know as well. The booklets are available at www.DrugFreeWorld.org.

Written in plain language, easy to understand, and available in 22 languages, this information explains the physical and mental effects of drugs on a person. It tells true stories of people who have used drugs and became addicted to them.

If someone is trying to push a drug on you, or if you are considering using a drug or are already using it, or if you know someone using drugs, check out the Drug-Free World website so you have all the information you need to make an informed decision.

The first segment, entitled The Truth About Drugs, gives a factual and concise overview of exactly what drugs are, how they work and what they do. It gives the street names as well as the long- and short-term side effects of the most common substances. As a booklet, it is the recommended general handout for distribution in any community and to share with friends, family and others.

Each individual drug has its own section with a lot more facts and stories of users. On the website, you can select which drug you want to read about.

The booklets and this site are resources for anyone—kids, parents, teachers, counselors, law enforcement officers, youth workers, drug prevention and rehabilitation specialists and health professionals.

The fourteen drug information booklets are also free and can be ordered as a set, or each one of them can be ordered separately in any quantity. You can easily request The Truth About Drugs booklets.

There are many local chapters of Drug-Free World around the United States that work with law enforcement, non profit and community groups. In Washington, DC, Drug-Free World volunteers regularly meet with the US Attorneys Office, DC Prevention Center, and other organizations working to defeat the opioid and Heroin epidemic.

The Truth About Drugs printed and audiovisual materials are intended and designed for use anywhere in the world—in schools, churches, community centers, governments, anywhere. This sampling of recent requests reflects the diversity:

Senior Education Program Specialist, Department of Education, Cabarrogius, Philippines:
“We are planning to have a province-wide campaign against drug abuse. Your materials shall be used in the classrooms. We are conceptualizing a division-wide campaign against drug addiction among students here at the Division of Quirino. The materials shall be given to schools for school children.”

VICE Project, Denmark:
“I am writing on behalf of VICE Denmark, where we are currently working on a documentary for Danish national television channel DR3. The program is about the growing use of party drugs amongst the youth, and what is being done to change this. I came across your videos, and we would love to use them as an example on the drug-free movement, and what is being done against drugs.”

“We are conceptualizing a division-wide campaign against drug addiction among students here at the Division of Quirino. The materials shall be given to schools for school children.” —Senior Education Program Specialist, Philippines

Former drug addict, Pretoria, South Africa:
“This drug education program is important to me in my plans to help addicts. I have 25 years of experience as an addict, two years clean now, with the desire to get addicts off the streets and to stop addiction in the early stages. I want to educate school children and companies and current drug users with the very professional information you provide. I can make a difference to others with my own story of addiction and your materials. This has been my desire for a long time, and if I can save lives, my life of addiction will be worth something.”

Chemistry Major, Northwestern Oklahoma State University, USA:
“I am doing independent research on prescription drug abuse by children, and your materials are helpful in my study which will benefit the community.”

Susan Taylor
Drug-Free World
202-667-6404
email us here


Source: EIN Presswire

FOR IMMEDIATE RELEASE: U.S. Reps. Charlie Crist and Guy Reschenthaler Introduce Petfax Act to Protect Pets and Consumers

The Petfax Act

The Petfax Act

Holly Gann, director of federal affairs at the Animal Wellness Foundation

Holly Gann, director of federal affairs at the Animal Wellness Foundation

Animal Wellness Action and Foundation Logo

Animal Wellness Action and Foundation Logo

Most dogs sold in pet stores come from puppy mills, where the dogs are treated like a cash crop. ”

— Holly Gann, director of federal affairs at Animal Wellness Action

WASHINGTON, DC, USA, January 30, 2020 /EINPresswire.com/ — Today U.S. Representatives Charlie Crist (D-FL) and Guy Reschenthaler (R-PA) introduced legislation in the U.S. House recognized as the “Petfax Act” to mandate honesty and transparency in the commercial sales of dogs and cats and crackdown on cruel “puppy mills”– large commercial dog breeding operations that breed high volumes of puppies to sell at pet stores and across the internet. It is the third anti-puppy mill bill introduced in this Congress – an indicator of the broad concern about the systematic mistreatment of dogs in large-scale commercial dog breeding operations.

Over 100,000 mother dogs are forced to suffer in puppy mills where they are forced to spend their entire lives in barren cages without ever touching a blade of grass. Horrific, painful injuries are commonplace and frequently go untreated. Puppies often become sick due to the unsanitary conditions of mills and long-distance transport to pet stores where they are sold to unsuspecting customers. It is not uncommon for pet stores to deny that the dogs come from puppy mills. Current laws barely meet survival standards, fail to adequately protect animals and consumers, and allow violators to continue renewing their license.

“Most dogs sold in pet stores come from puppy mills, where the dogs are treated like a cash crop,” stated Holly Gann, Director of Federal Affairs for the Animal Wellness Foundation and Animal Wellness Action, “If you buy a car, you can get a full history from Carfax; but when it comes to purchasing a puppy, sellers generally won’t provide information about where the dog came from or the dog’s medical history.”

“Welcoming a new pet into your home is a decision rooted in love. Pet owners deserve the peace of mind that their new family member wasn’t abused or mistreated by breeder or seller,” said Rep. Crist. “Requiring a Petfax increases transparency, decreasing the potential for animal abuse, a win-win for all parties involved.”

“Too many animals suffer from inhumane conditions in our nation,” said Reschenthaler. “The Petfax Act of 2020, bipartisan legislation I’m introducing with Rep. Crist, will better protect dogs and cats from neglect and abuse. By improving transparency and providing consumers with more information, including the source of their pet and its record on animal welfare inspections, we can hold irresponsible sellers of dogs and cats accountable. Given the proven ties between cruelty to animals and child and senior abuse, I will continue fighting to strengthen protections for our nation’s pets.”

The Petfax Act would:

Require that sellers of dogs and cats disclose certain information to a customer about the animals, including information identifying the dealer who bred the animals, the number of dogs bred and sold by that dealer over the past two years, a listing of any violations the dealer has had in the past two years, and health information about the animals, including whether a veterinarian was seen, vaccinations administered, and congenital disease. The Petfax Act would make it illegal for a seller, such as a pet store, to misrepresent the source of a dog or cat, including misrepresenting whether the animal came from a mill.

Require that animal welfare inspection records are reinstated on the USDA website, so that the public can look up a breeder prior to purchasing a dog to see if the breeder has violations. These records were previously available until being taken down by the USDA in 2017, eliminating transparency and allowing mills with violations to have no accountability.

Similar to another bill in Congress – the Welfare Of Our Friends (WOOF) Act – the bill closes a loophole that allows mills with violations to continue operating. The bill prohibits USDA from issuing or renewing a license to a dealer who has had a suspension within the past 10 years. It also prevents a license from being granted to the immediate family member of a dealer who has had their license suspended or revoked, to someone who resides at the same address, or to an entity where the dealer holds an ownership interest.

The Petfax Act for honesty in pet sales is the latest in local, state, and federal legislation to root out puppy mills. Two other bills have also been introduced in Congress: The WOOF Act would address loopholes to stop puppy mills with suspensions from continuing to operate, and the Puppy Protection Act would increase the standards of care for mother dogs kept in these mills. Over 300 localities across the nation have adopted legislation to prevent pet stores from selling puppies that come from puppy mills, and California and Maryland have adopted similar state legislation, with many more to follow.

The Animal Wellness Foundation (Foundation) is a Los Angeles-based private charitable organization with a mission of helping animals by making veterinary care available to everyone with a pet, regardless of economic ability. We organize rescue efforts and medical services for dogs and cats in need and help homeless pets find a loving caregiver. We are advocates for getting veterinarians to the front lines of the animal welfare movement; promoting responsible pet ownership; and vaccinating animals against infectious diseases such as distemper. We also support policies that prevent animal cruelty and that alleviate suffering. We believe helping animals helps us all.

Animal Wellness Action (Action) is a Washington, D.C.-based 501(c)(4) organization with a mission of helping animals by promoting legal standards forbidding cruelty. We champion causes that alleviate the suffering of companion animals, farm animals, and wildlife. We advocate for policies to stop dogfighting and cockfighting and other forms of malicious cruelty and to confront factory farming and other systemic forms of animal exploitation. To prevent cruelty, we promote enacting good public policies and we work to enforce those policies. To enact good laws, we must elect good lawmakers, and that’s why we remind voters which candidates care about our issues and which ones don’t. We believe helping animals helps us all.

Holly Gann
ANIMAL WELLNESS ACTION
+1 2024604289
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

COA Survey Finds OCM Participants Willing to Take on Two-Sided Risk

Practices in Oncology Care Model Confident They Can Succeed in Shift to Value-Based Cancer Care

The last three-and-a-half years have done much to educate and prepare teams for new models for cancer care.”

— Bo Gamble, Director of Strategic Initiatives, COA

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, January 30, 2020 /EINPresswire.com/ — Oncology practices participating in the Centers for Medicare & Medicaid Innovation’s Oncology Care Model (OCM) are willing to take on two-sided risk, according to the results of a survey conducted by the Community Oncology Alliance (COA). The results suggest that oncology practices are confident they can succeed in delivering high-quality and cost-effective cancer care as the health care system undergoes a paradigm shift from fee-for-service to value-based care.

COA surveyed OCM participants following the Center for Medicare & Medicaid Innovation (CMMI) December 3, 2019 deadline, by which practices had to decide whether to continue in the OCM program, as well as to commit to two-sided risk going forward. A total of 68 OCM practices responded to the 15-question survey which was available online between December 4-20, 2019. The survey results found:

– 47.1% (32 practices) opted to remain in the OCM with one-sided risk
– 36.8% (25 practices) chose to remain and enter into two-sided risk
– 32.4% (22 of the 25 practices) selected two-sided risk and had not received a single performance-based payment
– 16% (11 practices) said they were dropping out of the OCM
– Ten of the 11 practices leaving the OCM had not received a performance-based payment over the preceding four performance periods
– One practice indicated it had received at least one performance-based payment but opted to leave the OCM

Since the start of the OCM, COA has had more than 80 percent of OCM participants networked in an interactive “OCM Support Network” that includes regular calls and meetings, a dedicated listserv, access to subject matter experts, and more. The purpose is to support participants’ involvement and success in the OCM.

Following the December 3 deadline, only OCM teams that had received at least one performance-based payment (out of a possible four performance-based payments) could remain in the OCM without accepting two-sided risk. If practices remained in the OCM, they had to decide between one-sided risk or taking on two-sided risk. With two-sided risk, practices would have to pay back Medicare if they did not achieve the required cost savings. Practices that have not received a performance-based payment but wished to remain in the OCM were required to enter a two-sided risk arrangement.

The COA survey included questions about the practice’s prior OCM performance, its decision to continue or to withdraw from the program, its decision regarding two-sided risk, and whether the practice obtained reinsurance. Practices remaining in the OCM and taking on two-sided risk represent 679 MDs. The average practice size that is assuming two-sided risk is 29.5 MDs. The largest practice taking on two-sided risk in the survey has 160 MDs, and the smallest practice has two MDs.

According to COA’s Director of Strategic Initiatives, Bo Gamble, the survey results show that oncology teams have gained confidence with new models of cancer care. “The last three-and-a-half years have done much to educate and prepare teams for new models for cancer care,” Mr. Gamble said. “No longer are incentives purely about utilization. Now there are numerous attempts to design a model with emphasis on quality, value, and meaningful quantifiable outcomes. The OCM, and the 20-plus other models, are consistent with that message.”

Taking on Risk Without Performance-Based Payments

Only three practices (4.4%) that had achieved a performance-based payment during the previous four performance periods reported they were entering the two-sided risk arrangement. Most surprising was the number of practices, 22 (32.4%) that had not received any performance-based payments but decided to continue in the OCM taking on two-sided risk.

“These teams must feel good about their progress or they were comfortable with the safe zone option,” Mr. Gamble said. Seven (30%) of those practices were in the safe zone for all four performance periods; five (22%) were in the safe zone for three performance periods; nine (39%) were in the safe zone for two performance periods; and two (9%) practices were in the safe zone for one performance period.

The “safe zone,” introduced by CMS with the performance period three reconciliation reports, is when a practice’s actual costs fall between the OCM’s targeted and benchmark costs. The practice does not earn a performance-based payment, but it is also not responsible for costs exceeding the target amount. In other words, the practice does not owe money to CMS. For many OCM practices, the safe zone option has made two-sided risk more acceptable.

COA also included questions in the survey about reinsurance, an insurance product that helps protect providers against catastrophic downside risk. Six (24%) of the 25 teams taking on two-sided risk indicated they would purchase reinsurance to cover their potential losses, with 17 (68%) practices indicating they would not obtain reinsurance. Two practices were undecided. One practice indicated it may withdraw from the OCM if it is unable to obtain reinsurance by the end of the year.

Of note, the average practice size that is purchasing reinsurance (17 MDs) is smaller than the average practice size opting for two-sided risk. “This suggests the smaller practices have more to lose if they do not do well and therefore need some financial security,” Mr. Gamble said.

What Does the Future Hold for Oncology Practice Transformation?

The OCM has had a transformative effect on community oncology practices but implementation has been challenging, even for practices with previous payment reform experience. COA’s efforts to support and advocate for the OCM practices that have been struggling with implementation eventually led COA to begin developing its own payment model for cancer care based on quality and value. Known as the "OCM 2.0," it is a detailed alternative payment model (APM) that includes bold proposals for value-based drug contracts that, if implemented, would provide high-quality, coordinated oncology care at the same or lower cost.

Nicolas Ferreyros
Community Oncology Alliance
+1 2027298147
email us here


Source: EIN Presswire

Drug Manufacturers Continue to Raise Prices for Brand Drugs During the First Four Weeks of the New Year

AnalySource Logo

Drug With Price Increase At Least 10%

Capitol Hill Has Taken Notice and Pushing Their Solutions

SYRACUSE, NEW YORK, UNITED STATES, January 30, 2020 /EINPresswire.com/ — Four weeks into the new year, drug manufacturers continue to raise prices for brand name drugs with 55 brands increasing in week three and 4 more in week four. A total of 674 brands have taken price increases since January 1st averaging 5.3% vs 5.8% for the same time period last year, with eight drugs having price increases of at least 10.0% (See chart). Among brands having price increases this year is Humira (AbbVie) up 7.4%, Eliquis (Bristol-Myers Squibb) up 6.0%, Keytruda (Merck) up 1.5%, Oxycontin (Purdue Pharma) up 5.0%, Revlimid (Celgene) up 6.0%, and Cosentyx (Novartis) up 7.0%.

Overall, price changes range from a low of -97.4% for Cleocin HCL, used to treat a wide variety of bacterial infections, to a high of 15.0% for both HEPARIN SODIUM and HEPARIN SODIUM-D5W, used to treat blood clots. The average price change of all brand drugs is 3.6% (vs 5.2% last year).

These price changes affect list prices, or Wholesale Acquisition Cost* (WAC), that are set by the drug manufacturers without taking into account rebates, insurance and other discounts that may be available.

With rising drug prices being one of the biggest health care concerns in America, Capitol Hill has taken notice and both sides of the aisle have been pushing their own solutions, such as allowing the importation of drugs from other countries, empowering the Health & Human Services (HHS) secretary to negotiate the best prices on certain medications or tying drug pricing to inflation forcing drug makers to pay penalties if, on certain medications, prices rise faster than the rate of inflation (CPI-U).

Source
AnalySource® as of Jan 28, 2020 – Reprinted with permission by First Databank, Inc. All rights reserved. © 2020

* First Databank, Inc Drug Pricing Policy: https://www.fdbhealth.com/drug-pricing-policy

About DMD America, Inc
AnalySource® is a registered trademark and drug pricing data solution service of DMD America, Inc. Since 1996, data has been made available in cooperation with First Databank, Inc. a subsidiary of the Hearst Corporation. Our service is licensed by subscription, with global clients including biotech, pharmaceuticals, government agencies, consultancies, academia, and more.

Eric Tedford
DMD America
+1 315-671-4208
email us here


Source: EIN Presswire

Mrs. Monika Kryemadhi and Socialist Movement for Integration Party delegation visit Ashraf-3

Ashraf-3, Albania, January 29, 2020 - Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party (Left), and Mrs. Maryam Rajavi, NCRI’s President-elect, with thousands of members of the Mujahedin-e Khalq (PMOI/MEK)

Ashraf-3, Albania, January 29, 2020 – Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party (Left), and Mrs. Maryam Rajavi, NCRI’s President-elect, with thousands of members of the Mujahedin-e Khalq (PMOI/MEK).

Ashraf-3, Albania, January 29, 2020 - Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party (Left), heading a delegation of the party in her visit to Ashraf-3 and meeting with Mrs. Maryam Rajavi, the NCRI President-elect

Ashraf-3, Albania, January 29, 2020 – Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party (Left), heading a delegation of the party in her visit to Ashraf-3 and meeting with Mrs. Maryam Rajavi, the NCRI President-elect.

Ashraf-3, Albania, January 29, 2020 - Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party, and Mrs. Maryam Rajavi, the President-elect of the NCRI, visiting the Museum of 120 Years of Struggle for Freedom in Iran

Ashraf-3, Albania, January 29, 2020 – Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party, and Mrs. Maryam Rajavi, the President-elect of the NCRI, visiting the Museum of 120 Years of Struggle for Freedom in Iran.

Ashraf-3, Albania, January 29, 2020 - Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party, and Mrs. Maryam Rajavi, the NCRI President-elect, holding the recently published book by the Iranian Resistance, entitled, “Crime Against Humanity”

Ashraf-3, Albania, January 29, 2020 – Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party, and Mrs. Maryam Rajavi, the NCRI President-elect, holding the recently published book by the Iranian Resistance, entitled, “Crime Against Humanity” .

Ashraf-3, Albania, January 29, 2020 - Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party, and Mrs. Maryam Rajavi, the President-elect of the NCRI, visiting the Museum of 120 Years of Struggle for Freedom in Iran

Ashraf-3, Albania, January 29, 2020 – Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party, and Mrs. Maryam Rajavi, the President-elect of the NCRI, visiting the Museum of 120 Years of Struggle for Freedom in Iran.

Ashraf-3, Albania, January 29, 2020 - Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party, heading a delegation of the party meeting with Mrs. Maryam Rajavi, the NCRI President-elect. To her left are Mr. Petrit Vasili, Deputy

Ashraf-3, Albania, January 29, 2020 – Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party, heading a delegation of the party meeting with Mrs. Maryam Rajavi, the NCRI President-elect. To her left are Mr. Petrit Vasili, Deputy

Ashraf-3, Albania, January 29, 2020 - Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party, and Mrs. Maryam Rajavi, the President-elect of the NCRI, visiting the Museum of 120 Years of Struggle for Freedom in Iran.

Ashraf-3, Albania, January 29, 2020 – Mrs. Monika Kryemadhi, Chairwoman of the Socialist Movement for Integration Party, and Mrs. Maryam Rajavi, the President-elect of the NCRI, visiting the Museum of 120 Years of Struggle for Freedom in Iran.

I felt privileged to have been given the opportunity to visit the Ashraf-3 museum and sense the strength of women and men in your movement in the way they fought for democracy in Iran”

— Monika Kryemadhi

PARIS, FRANCE, January 30, 2020 /EINPresswire.com/ — On Wednesday, January 29, 2020, Mrs. Monika Kryemadhi, heading a delegation from the Socialist Movement for Integration Party, visited Ashraf-3 and met with Mrs. Maryam Rajavi, the President-elect of the National Council of Resistance of Iran (NCRI).

In addition to Chairwoman, other members of the delegation included Mr. Petrit Vasili, Deputy Chair, and Mr. Eriol Braimllari, her Chief of Staff.

Chairwoman Kryemadhi and the accompanying delegation toured the Museum of 120 Years of Struggle for Freedom in Iran at Ashraf-3.

The delegation also visited thousands of members of the Mujahedin-e Khalq (PMOI/MEK) in Ashraf-3, which Mrs. Kryemadhi described as “a beautiful city.”

Expressing her pleasure in meeting the combatants of Iran’s freedom, Mrs. Kryemadhi said that she had been quite moved during her visit to the museum. “What I saw, was shocking. But I felt privileged to have been given the opportunity to visit the museum and sensed the strength of women and men in your movement in the way they fought for democracy in Iran. I learned a lot from my visit,” Mrs. Kryemadhi noted.

Noting that “Albania and Albanian people are known for their hospitality toward people driven from their home,” Chairwoman Kryemadhi added, “In your museum and in the book of martyrs, I found the force and motivation of the Iranian Resistance to fight for freedom and democracy. This is the same force that enabled the people of Albania to achieve freedom and democracy.” She said, “I now understand why the regime in Iran is so afraid of you because you have the mindset and the mentality to bring democracy to your country, something which is reflected in your Ten-point Plan.”

Mrs. Rajavi welcomed Chairwoman Kryemadhi and her delegation. Expressing her gratitude over the hospitality of the people of Albania, she said we are delighted to enjoy cross-party support in Albania. Today, the Iranian people are at a watershed moment in their history. The uprisings in November 2019 and January 2020 again demonstrated that the people of Iran, especially the youth and the Resistance Units, are determined to end the religious dictatorship with all its factions. To achieve freedom, they are willing to pay whatever price. I have no doubt that Iran will be free very soon.

Mrs. Rajavi added that the expulsion of the Iranian regime’s ambassador and three other so-called diplomats from Albania reflected the vigilance and decisiveness exercised by Albania and a sign of that country’s commitment to humanitarian values. It also made it abundantly clear that the religious, terrorist dictatorship ruling our nation can neither change its nature nor its behavior.

The NCRI’s President-elect said Albania’s actions vis-à-vis the Iranian regime must serve as an example for all countries, especially in Europe. The policy of appeasing the regime, which paved the way for terrorism, must be abandoned. It is time to adopt a decisive policy towards the godfather of terrorism and fundamentalism. Any investment in this moribund regime is doomed to failure.

Secretariat of the National Council of Resistance of Iran
January 30, 2020

Shahin Gobadi
NCRI
+33 6 50 11 98 48
email us here


Source: EIN Presswire

Global Cash Logistics Market 2020 Key Players, Share, Trend, Segmentation and Forecast to 2026

New Study Reports "Cash Logistics Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports.

PUNE, MAHARASHTRA, INDIA, January 30, 2020 /EINPresswire.com/ — Cash Logistics Market 2020-2026

New Study Reports "Cash Logistics Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports.

Introduction/Report Summary:

This report provides in depth study of “Cash Logistics Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Cash Logistics Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The global market for cash logistics services has been influenced positively by the rising security concerns amongst banks and corporate houses which require secure movement and management services for cash. Growing ATM market has resulted in rise in demand for cash logistics services.

The Global Cash Logistics market has witnessed stable growth in the demand for the cash logistics as well as management services. While apprehension to use electronic payment systems and penetration of ATMs is conducive to the growth of the market, popularity of plastic money and mobile wallets is adversely affecting the market prospects.

Key Players

The report has profiled some of the Important players prevalent in the global like – Brink's Incorporated, G4S
GardaWorld
Loomis
Prosegur
Cash Logistik Security
Global Security Logistics
General Secure Logistics Services
Lemuir Secure Logistics, and more.

This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the Cash Logistics.

Request for Free Sample Report of “Cash Logistics” Market @  https://www.wiseguyreports.com/sample-request/4864175-global-cash-logistics-market-professional-survey-2019-by

Market Segmentation based On Type, Application and Region:

The global Cash Logistics is analyzed for different segments to arrive at an insightful analysis. Such segmentation has been done based on type, application, and region.

Based on type, the global Cash Logistics Market is segmented into Cash-In-Transit, Cash Management, ATM Services and other

Based on application, the Cash Logistics Market is segmented into Enterprise, Individual, Government and Others.

Based on Detailed Regional Analysis, the regional segmentation has been carried out for regions of U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report on WGR includes an in-depth study of the Cash Logistics in each regional segment mentioned above.

Key Stakeholders 
Cash Logistics Market Manufacturers 
Cash Logistics Market Distributors/Traders/Wholesalers 
Cash Logistics Market Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/4864175-global-cash-logistics-market-professional-survey-2019-by

Major Key Points from Table of Content:

1 Industry Overview of Cash Logistics
1.1 Brief Introduction of Cash Logistics
1.1.1 Definition of Cash Logistics
1.1.2 Development of Cash Logistics Industry
1.2 Classification of Cash Logistics
1.3 Status of Cash Logistics Industry
1.3.1 Industry Overview of Cash Logistics
1.3.2 Global Major Regions Status of Cash Logistics

2 Industry Chain Analysis of Cash Logistics

3 Manufacturing Technology of Cash Logistics

4 Major Manufacturers Analysis of Cash Logistics
4.1 Brink's Incorporated
4.1.1 Company Profile
4.1.2 Product Picture and Specifications
4.1.3 Capacity, Production, Price, Cost, Gross and Revenue
4.1.4 Contact Information
4.2 G4S
4.2.1 Company Profile
4.2.2 Product Picture and Specifications
4.2.3 Capacity, Production, Price, Cost, Gross and Revenue
4.2.4 Contact Information

and more

Continued…

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here


Source: EIN Presswire

Automobile High-strength Steel Market 2020 Company Profiles, Size, Share and Market Intelligence Forecast To 2025

Automobile High-strength Steel -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025

PUNE, MAHARASHTRA, INDIA, January 30, 2020 /EINPresswire.com/ — Automobile High-strength Steel Industry

Description

The market report on the Automobile High-strength Steel Market provides comprehensive information on the overall Automobile High-strength Steel Market. The report provides definitions of the products, services along with the various applications of those products in the market. The variety of end-users and the technology used for product manufacturing in the Automobile High-strength Steel Market is also defined in the market report. The report on the global Automobile High-strength Steel Market provides information about some of the leading trends and dynamics for the review period 2020 to 2025.

The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Automobile High-strength Steel by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Swedish Steel?SSAB?
Nippon Steel & Sumitomo Metal
ThyssenKrupp
ArcelorMittal
Baosteel Group
Kobe Steel
POSCO
Ansteel
BX STEEl
Shougang Group

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/4899546-global-automobile-high-strength-steel-market-analysis-2015

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Dual Phase Steels
Complex Phase Steels
Transformation Induced Plasticity Steels
Martensitic Steels
Quenching and Partitioning Steels
Twinning Induced Plasticity Steels
Press Hardening/Boron Steels

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
A Pillar
B Pillar
Reinforced Sill
Roof Cross-Rail
Longeron Assembles
Door Panel
Trunk Lid
Others

Regional Description

The report on the global Automobile High-strength Steel Market makes divisions of the whole market into several regions that include South America, Europe, the Middle East, Africa, Asia-Pacific, and North America among others. This segmentation helps in the data analysis of the development of the market in the key regions mentioned. The key markets and countries along with key players in the industry operating in these areas have been identified.

Method of Research

Addressing the various factors that can affect the Automobile High-strength Steel Market, the report provides extensive research into the market at a global level. The study includes incorporates various research methodologies to determine the overall size of the Automobile High-strength Steel Market. Regarding the major manufacturers, a SWOT analysis report has been prepared in order to identify the strengths, weaknesses, opportunities, and threats that are faced by each of them listed in the report.

Leave a Query @ https://www.wiseguyreports.com/enquiry/4899546-global-automobile-high-strength-steel-market-analysis-2015

Table of Content

1 Industry Overview
1.1 Automobile High-strength Steel Industry
Figure Automobile High-strength Steel Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Automobile High-strength Steel
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Automobile High-strength Steel
1.2.2 Downstream
Table Application Segment of Automobile High-strength Steel
Table Global Automobile High-strength Steel Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

4 Major Companies List
4.1 Swedish Steel?SSAB? (Company Profile, Sales Data etc.)
4.1.1 Swedish Steel?SSAB? Profile
Table Swedish Steel?SSAB? Overview List
4.1.2 Swedish Steel?SSAB? Products & Services
4.1.3 Swedish Steel?SSAB? Business Operation Conditions
Table Business Operation of Swedish Steel?SSAB? (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Nippon Steel & Sumitomo Metal (Company Profile, Sales Data etc.)
4.2.1 Nippon Steel & Sumitomo Metal Profile
Table Nippon Steel & Sumitomo Metal Overview List
4.2.2 Nippon Steel & Sumitomo Metal Products & Services
4.2.3 Nippon Steel & Sumitomo Metal Business Operation Conditions
Table Business Operation of Nippon Steel & Sumitomo Metal (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 ThyssenKrupp (Company Profile, Sales Data etc.)
4.3.1 ThyssenKrupp Profile
Table ThyssenKrupp Overview List
4.3.2 ThyssenKrupp Products & Services
4.3.3 ThyssenKrupp Business Operation Conditions
Table Business Operation of ThyssenKrupp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 ArcelorMittal (Company Profile, Sales Data etc.)
4.4.1 ArcelorMittal Profile
Table ArcelorMittal Overview List
4.4.2 ArcelorMittal Products & Services
4.4.3 ArcelorMittal Business Operation Conditions
Table Business Operation of ArcelorMittal (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Baosteel Group (Company Profile, Sales Data etc.)
4.5.1 Baosteel Group Profile
Table Baosteel Group Overview List
4.5.2 Baosteel Group Products & Services
4.5.3 Baosteel Group Business Operation Conditions
Table Business Operation of Baosteel Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Kobe Steel (Company Profile, Sales Data etc.)
4.7 POSCO (Company Profile, Sales Data etc.)
4.8 Ansteel (Company Profile, Sales Data etc.)
4.9 BX STEEl (Company Profile, Sales Data etc.)
4.10 Shougang Group (Company Profile, Sales Data etc.)

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=4899546

Continued…            

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

Automotive Telematics System Market 2020: Global Analysis, Share, Trends, Application Analysis and Forecast To 2025

Automotive Telematics System -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025

PUNE, MAHARASHTRA, INDIA, January 30, 2020 /EINPresswire.com/ — Automotive Telematics System Industry

Description

The market report on the Automotive Telematics System Market provides comprehensive information on the overall Automotive Telematics System Market. The report provides definitions of the products, services along with the various applications of those products in the market. The variety of end-users and the technology used for product manufacturing in the Automotive Telematics System Market is also defined in the market report. The report on the global Automotive Telematics System Market provides information about some of the leading trends and dynamics for the review period 2020 to 2025.

The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Automotive Telematics System by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Agero Inc
Airbiquity Inc
At&T, Inc.
Continental Ag
Delphi Automotive Plc
Intel Corporation
Magneti Marelli S.P.A
Mix Telematics
Robert Bosch Gmbh
Verizon Communications Inc
Visteon Corporation
Wirelesscar

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/4899580-global-automotive-telematics-system-market-analysis-2015-2019

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Embedded Type
Tethered Type
Integrated Type

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Passenger Cars
Light Commercial Vehicles (LCVS)
Heavy Commercial Vehicles (HCVS)

Regional Description

The report on the global Automotive Telematics System Market makes divisions of the whole market into several regions that include South America, Europe, the Middle East, Africa, Asia-Pacific, and North America among others. This segmentation helps in the data analysis of the development of the market in the key regions mentioned. The key markets and countries along with key players in the industry operating in these areas have been identified.

Method of Research

Addressing the various factors that can affect the Automotive Telematics System Market, the report provides extensive research into the market at a global level. The study includes incorporates various research methodologies to determine the overall size of the Automotive Telematics System Market. Regarding the major manufacturers, a SWOT analysis report has been prepared in order to identify the strengths, weaknesses, opportunities, and threats that are faced by each of them listed in the report.

Leave a Query @ https://www.wiseguyreports.com/enquiry/4899580-global-automotive-telematics-system-market-analysis-2015-2019

Table of Content

1 Industry Overview
1.1 Automotive Telematics System Industry
Figure Automotive Telematics System Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Automotive Telematics System
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Automotive Telematics System
1.2.2 Downstream
Table Application Segment of Automotive Telematics System
Table Global Automotive Telematics System Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

….

4 Major Companies List
4.1 Agero Inc (Company Profile, Sales Data etc.)
4.1.1 Agero Inc Profile
Table Agero Inc Overview List
4.1.2 Agero Inc Products & Services
4.1.3 Agero Inc Business Operation Conditions
Table Business Operation of Agero Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Airbiquity Inc (Company Profile, Sales Data etc.)
4.2.1 Airbiquity Inc Profile
Table Airbiquity Inc Overview List
4.2.2 Airbiquity Inc Products & Services
4.2.3 Airbiquity Inc Business Operation Conditions
Table Business Operation of Airbiquity Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 At&T, Inc. (Company Profile, Sales Data etc.)
4.3.1 At&T, Inc. Profile
Table At&T, Inc. Overview List
4.3.2 At&T, Inc. Products & Services
4.3.3 At&T, Inc. Business Operation Conditions
Table Business Operation of At&T, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Continental Ag (Company Profile, Sales Data etc.)
4.4.1 Continental Ag Profile
Table Continental Ag Overview List
4.4.2 Continental Ag Products & Services
4.4.3 Continental Ag Business Operation Conditions
Table Business Operation of Continental Ag (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Delphi Automotive Plc (Company Profile, Sales Data etc.)
4.5.1 Delphi Automotive Plc Profile
Table Delphi Automotive Plc Overview List
4.5.2 Delphi Automotive Plc Products & Services
4.5.3 Delphi Automotive Plc Business Operation Conditions
Table Business Operation of Delphi Automotive Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Intel Corporation (Company Profile, Sales Data etc.)
4.6.1 Intel Corporation Profile
Table Intel Corporation Overview List
4.6.2 Intel Corporation Products & Services
4.6.3 Intel Corporation Business Operation Conditions
Table Business Operation of Intel Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Magneti Marelli S.P.A (Company Profile, Sales Data etc.)
4.8 Mix Telematics (Company Profile, Sales Data etc.)
4.9 Robert Bosch Gmbh (Company Profile, Sales Data etc.)
4.10 Verizon Communications Inc (Company Profile, Sales Data etc.)
4.11 Visteon Corporation (Company Profile, Sales Data etc.)
4.12 Wirelesscar (Company Profile, Sales Data etc.)

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=4899580

Continued…            

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire

Dermal filler and Botolinum Toxin Market 2020 Global Trend, Segmentation And Opportunities Forecast To 2025

Dermal filler and Botolinum Toxin -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025

PUNE, MAHARASHTRA, INDIA, January 30, 2020 /EINPresswire.com/ — Dermal filler and Botolinum Toxin Industry

Description

The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Dermal filler and Botolinum Toxin by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

The report published on the Dermal filler and Botolinum Toxin Market gives a comprehensive analysis of the market studying the popular trends. The current market scenario has been evaluated and the forecast for the same has been provided based on the data collected from the previous years. The industry overview provided in this report also studies the technological and commercial aspects of the market while covering the key market players. The market shares and market concentration have been studied for each of the companies. The market has been covered for the assessment period of 2020 to 2025.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Allergan plc.
Galderma SA
Merz Pharma GmbH & Co. KGaA
Anika Therapeutics, Inc.
Suneva Medical, Inc.
Speciality European Pharma
HUGEL, Inc.
Grex Pharma SaS
Daewoong Pharmaceuticals
Medy-Tox Inc.
TEOXANE Laboratories
SciVision Biotech Inc.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/4900528-global-dermal-filler-and-botolinum-toxin-market-analysis

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Aesthetic Volume Restoration
Wrinkle Reduction

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin

Regional Description

The report on the global Dermal filler and Botolinum Toxin Market makes divisions of the whole market into several regions that include South America, Europe, the Middle East, Africa, Asia-Pacific, and North America among others. This segmentation helps in the data analysis of the development of the market in the key regions mentioned. The key markets and countries along with key players in the industry operating in these areas have been identified. The current status of the regional markets along with the forecast is presented in detail in the global Dermal filler and Botolinum Toxin Market report.

Method of Research

Addressing the various factors that can affect the Dermal filler and Botolinum Toxin Market, the report provides extensive research into the market at a global level. The study includes incorporates various research methodologies to determine the overall size of the Dermal filler and Botolinum Toxin Market. Regarding the major manufacturers, a SWOT analysis report has been prepared in order to identify the strengths, weaknesses, opportunities, and threats that are faced by each of them listed in the report. The report also includes an analysis of the five forces that comprise Porter’s Five Forces model. 

Leave a Query @ https://www.wiseguyreports.com/enquiry/4900528-global-dermal-filler-and-botolinum-toxin-market-analysis

Table of Content

1 Industry Overview
1.1 Dermal filler and Botolinum Toxin Industry
Figure Dermal filler and Botolinum Toxin Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Dermal filler and Botolinum Toxin
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Dermal filler and Botolinum Toxin
1.2.2 Downstream
Table Application Segment of Dermal filler and Botolinum Toxin
Table Global Dermal filler and Botolinum Toxin Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis

2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

4 Major Companies List
4.1 Allergan plc. (Company Profile, Sales Data etc.)
4.1.1 Allergan plc. Profile
Table Allergan plc. Overview List
4.1.2 Allergan plc. Products & Services
4.1.3 Allergan plc. Business Operation Conditions
Table Business Operation of Allergan plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Galderma SA (Company Profile, Sales Data etc.)
4.2.1 Galderma SA Profile
Table Galderma SA Overview List
4.2.2 Galderma SA Products & Services
4.2.3 Galderma SA Business Operation Conditions
Table Business Operation of Galderma SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Merz Pharma GmbH & Co. KGaA (Company Profile, Sales Data etc.)
4.3.1 Merz Pharma GmbH & Co. KGaA Profile
Table Merz Pharma GmbH & Co. KGaA Overview List
4.3.2 Merz Pharma GmbH & Co. KGaA Products & Services
4.3.3 Merz Pharma GmbH & Co. KGaA Business Operation Conditions
Table Business Operation of Merz Pharma GmbH & Co. KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Anika Therapeutics, Inc. (Company Profile, Sales Data etc.)
4.5 Suneva Medical, Inc. (Company Profile, Sales Data etc.)
4.6 Speciality European Pharma (Company Profile, Sales Data etc.)
4.7 HUGEL, Inc. (Company Profile, Sales Data etc.)
4.8 Grex Pharma SaS (Company Profile, Sales Data etc.)
4.9 Daewoong Pharmaceuticals (Company Profile, Sales Data etc.)
4.10 Medy-Tox Inc. (Company Profile, Sales Data etc.)
4.11 TEOXANE Laboratories (Company Profile, Sales Data etc.)
4.12 SciVision Biotech Inc. (Company Profile, Sales Data etc.)

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=4900528

Continued…            

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349
email us here


Source: EIN Presswire